Aster DM Healthcare Acquires Full Stake in Sarjapur Entity, Securing 100% Control of New Specialty Hospital
Aster DM Healthcare Limited has completed the acquisition of equity shares in Aster DM Super-Specialty Hospital (Sarjapur) Private Limited, securing 100% control over the entity. The transaction involves the purchase of 4,50,89,995 equity shares through a rights issue in the Sarjapur Entity.The company acquired all necessary shares for its wholly owned subsidiary, Aster DM Super-Specialty Hospital (Sarjapur) Private Limited, which operates in the healthcare services industry. The investment was made for the general corporate purposes of the entity.
Acquisition Transaction Details
Details regarding the acquisition and the target entity are summarized below:| Particulars | Detail |
|---|---|
| Target Entity Name | Aster DM Super-Specialty Hospital (Sarjapur) Private Limited |
| Industry | Healthcare services |
| Shares Acquired | 4,50,89,995 equity shares of Rs. 10/- each |
| Total Acquisition Cost | Rs. 45,08,99,950/- |
| Percentage Shareholding | 100% |
| Entity Incorporation Date | July 21, 2025 |
Target Entity Profile
Aster DM Super-Specialty Hospital (Sarjapur) Private Limited was incorporated on July 21, 2025, in Bengaluru, Karnataka, India. The entity is dedicated to setting up and operating healthcare services. As of the date, turnover details are not applicable as the business is yet to commence.The acquisition represents the completion of a transaction between the holding company and its wholly owned subsidiary.
ASTERDM Stock Price Movement
As of 1:07 PM, shares of Aster DM Healthcare Limited are edging higher to ₹780.95, gaining 1.96% in live trading. The stock is experiencing robust interest, with a total traded volume tallying 166,027 shares during the ongoing market session.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.